Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.
Journal of Microbiology and Biotechnology
Condition  Expression
When you enter More than two words, please use ‘and , or’ operation by means of putting ‘,(Comma Mark)’ between each word.

2011 ; 21(6): 659~664

AuthorInger Mattsby-Baltzer, Tomas Bergstrom, Keith McCrea, Robert Ward, Lars Adolfsson, Olle Larm
AffiliationDepartment of Infectious Diseases/Clinical Bacteriology, University of Gothenburg, Guldhedsgatan 413 46, Gothenburg, Sweden
TitleAffinity Apheresis for Treatment of Bacteremia Caused by Staphylococcus aureus and/or Methicillin-Resistant S. aureus (MRSA)
PublicationInfo J. Microbiol. Biotechnol.2011 ; 21(6): 659~664
AbstractStaphylococcus aureus (SA) bacteremia is associated with high mortality, and often results in metastatic infections. The methicillin-resistant SA (MRSA) is an urgent health care issue, as nosocomial infections with these bacteria represent limited treatment alternatives. Samples of whole blood containing challenge inoculums of SA and MRSA strains were passed through columns packed with surfaceheparinized polyethylene beads. The bound bacteria were eluted and quantitatively determined by culturing and by real-time PCR. Significant amounts of both SA and MRSA adhered to the heparinized beads (more than 65% of inoculated bacteria). After rinsing with buffer at high ionic strength, viable bacteria or bacterial DNA were eluted from the columns, indicating that the binding was specific. The conclusions that can be made from these experiments are that, as earlier reported in the literature, the high affinity of SA to heparin is retained in whole blood, and MRSA in whole blood binds to heparin with similar or higher affinity than SA. It should be possible to lower the amount of SA and/or MRSA from the blood of infected patients to levels that could be taken care of by the immune system. In previous studies, we have shown that passing blood from septic patients over beads coated with end-point-attached, biologically active heparin is a useful technique for regulating the levels of heparinbinding cytokine. These findings in combination with the present findings indicate the possibility of creating an apheresis technology for treatment of sepsis caused by SA and/or MRSA.
Full-Text(PDF)
KeywordsImmobilized heparin, bacteria, Staphylococcus aureus, MRSA, aphaeresis
References
1. Axelsson, J., M. Ferreira, L. Adolfsson, K. McCrea, R. Ward, and O. Larm. 2010 Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J. Cytokines in blood from septic patients interact with surface-immobilized heparin. 56: 48-51
  

2. Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992 Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. 30: 1654-1660
  

3. Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001 Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. Neisseria meningitidis lipopolysaccharides in human pathology. J. 7: 401-420
 

4. Cai, B., E. A. Deitch, and L. Ulloa. 2010 Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462.  : -
   

5. Carleton, H. A., B. A. Diep, E. D. Charlebois, G. F. Sensabaugh, and F. Perdreau-Remington. 2004 Community-adapted methicillinresistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. Community-adapted methicillinresistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. 190: 1730-1738
  

6. Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003 Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. 36: 53-59
  

7. David, M. Z. and R. S. Daum. 2010 Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. 23: 616-687
  

8. Hackett, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002 Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. 86: 44-46
   

9. Hess, D. J., M. J. Henry-Stanley, S. L. Erlandsen, and C. L. Wells. 2006 Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. 195: 133-141
  

10. Hsu, R. B. 2005 Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. 26: 654-657
  

11. Jessen, M. E. 2006 Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesth. Analg. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesth. 103: 1365-1369
 

12. Kollef, M. H. 2000 Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4): S131-S138.  : -
  

13. Lala, H. M., G. D. Mills, K. Barratt, J. Bonning, N. E. Manikkam, and D. Martin. 2007 Meningococcal disease deaths and the frequency of antibiotic administration delays. J. Infect. Meningococcal disease deaths and the frequency of antibiotic administration delays. J. 54: 551-557
  

14. Larm, O., R. Larsson, and P. Olsson. 1983 A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11: 161-173.  : -
 

15. Liang, O. D., F. Ascencio, L. A. Fransson, and T. Wadstrom. 1992 Binding of heparan sulfate to Staphylococcus aureus. Infect. Immun. Binding of heparan sulfate to Staphylococcus aureus. Infect. 60: 899-906
  

16. Liang, O. D., F. Ascencio, R. Vazquezjuarez, and T. Wadstrom. 1993 Binding of collagen, fibronectin, lactoferrin, laminin, vitronectin and heparan-sulfate to Staphylococcus aureus strain- V8 at various growth phases and under nutrient stress conditions. Zentralbl. Bakteriol. Microbiol. Hyg. A 279: 180-190.  : -


17. Lisboa, T., G. Waterer, and J. Rello. 2010 We should be measuring genomic bacterial load and virulence factors. Crit. Care Med. 38: S656-S662.  : -
  

18. Ljungh, A. and T. Wadstrom. 1995 Growth-conditions influence expression of cell-surface hydrophobicity of staphylococci and other wound-infection pathogens. Microbiol. Immunol. Growth-conditions influence expression of cell-surface hydrophobicity of staphylococci and other wound-infection pathogens. Microbiol. 39: 753-757
 

19. Lowy, F. D. 1998 Staphylococcus aureus infections. N Engl. J. Med. Staphylococcus aureus infections. N Engl. J. 339: 520-532
  

20. Olofsson, S. and T. Bergstrom. 2005 Glycoconjugate glycans as viral receptors. Ann. Med. Glycoconjugate glycans as viral receptors. Ann. 37: 154-172
  

21. Ovstebo, R., P. Brandtzaeg, B. Brusletto, K. B. Haug, K. Lande, E. A. Hoiby, and P. Kierulf. 2004 Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal dis Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides 42: 2980-2987
   

22. Payen, D., J. Mateo, J. M. Cavaillon, F. Fraisse, C. Floriot, and E. Vicaut. 2009 Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit. Care Med. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit. 37: 803-810
  

23. Pertosa, G., G. Grandaliano, L. Gesualdo, and F. P. Schena. 2000 Clinical relevance of cytokine production in hemodialysis. Kidney Int. 76: S104-S111.  : -
 

24. Peters, R. P., M. A. van Agtmael, S. Gierveld, S. A. Danner, A. B. Groeneveld, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2007 Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin. Microbiol. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin. 45: 3641-3646
   

25. Rello, J., T. Lisboa, M. Lujan, M. Gallego, C. Kee, I. Kay, D. Lopez, and G. W. Waterer. 2009 Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136: 832-840.  : -
  

26. Riesenfeld, J. and L. Roden. 1990 Quantitative analysis of Nsulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Anal. Biochem. Quantitative analysis of Nsulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Anal. 188: 383-389
 

27. Ronco, C., R. Bellomo, P. Homel, A. Brendolan, M. Dan, P. Piccinni, and G. La Greca. 2000 Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30.  : -
 

28. Schefold, J. C., S. von Haehling, M. Corsepius, C. Pohle, P. Kruschke, H. Zuckermann, H. D. Volk, and P. Reinke. 2007 A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complementactivating product 5a. Shock 28: 418-425.  : -
  

29. Segreti, J. 2005 Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin. Microbiol. Infect. 11 (Suppl 3): 29-35.  : -
  

30. Tang, L. and J. W. Eaton. 1995 Inflammatory responses to biomaterials. Am. J. Clin. Pathol. Inflammatory responses to biomaterials. Am. J. Clin. 103: 466-471
 

31. Tetta, C., V. D’Intini, R. Bellomo, M. Bonello, V. Bordoni, Z. Ricci, and C. Ronco. 2003 Extracorporeal treatments in sepsis: Are there new perspectives? Clin. Nephrol. Extracorporeal treatments in sepsis: Are there new perspectives? Clin. 60: 299-304
 

32. Wadstrom, T. and A. Ljungh. 1999 Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J. Med. Microbiol. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J. Med. 48: 223-233
  

33. Valente, A. M., R. Jain, M. Scheurer, V. G. Fowler Jr., G. R. Corey, A. R. Bengur, S. Sanders, and J. S. Li. 2005 Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115: e15-e19.  : -
 

34. van der Poll, T. and S. M. Opal. 2008 Host-pathogen interactions in sepsis. Lancet Infect. Dis. Host-pathogen interactions in sepsis. Lancet Infect. 8: 32-43
 

35. van Haeften, R., S. Palladino, I. Kay, T. Keil, C. Heath, and G. W. Waterer. 2003 A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn. Microbiol. Infect. Dis. A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn. Microbiol. Infect. 47: 407-414
 

36. Venkataraman, R., S. Subramanian, and J. A. Kellum. 2003 Clinical review: Extracorporeal blood purification in severe sepsis. Crit. Care 7: 139-145.  : -
   

37. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004 Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. 39: 309-317
  

Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang.co., Ltd